Focus: Agilent is a Belgium-based biotechnology company specializing in high-throughput screening equipment and imaging instruments for drug discovery and development. The company operates across multiple therapeutic areas including neurology, gastroenterology, ophthalmology, cell therapy, and respiratory diseases.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Hot — 723 jobs added in 30d
Net +517 (723 new, 206 removed). Aggressive expansion phase.
Best suited for engineers and commercial professionals seeking growth at a hardware-focused biotech; less compelling for pipeline-driven scientists or those seeking established clinical validation.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Agilent
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Agilent's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub